IL1RAP and Merkel cell skin cancer: Several studies underscore a versatile role of the IL-33/T2-IL1RAcP pathway in the tumor microenvironment and tumorigenesis [20,29], thus making these proteins attractive therapeutic targets and potential biomarkers in MCC.